BD 515003 - Injector N35 for PhaSeal Closed-System Transfer Device Component for Hazardous Drug Safety , 200 EA/CS

BD 515003 - Injector N35 for PhaSeal Closed-System Transfer Device Component for Hazardous Drug Safety , 200 EA/CS

The BD 515003 Injector N35 is a critical component of the BD PhaSeal closed-system transfer device (CSTD), engineered to protect healthcare workers, patients, and environments from exposure to hazardous drugs. The Injector N35 connects securely to vials or syringes within the PhaSeal system, enabling airtight, leak-resistant transfers of chemotherapy medications and other cytotoxic agents. Its design ensures a fully enclosed fluid path, preventing aerosolization, vapor release, and accidental spills during drug preparation and administration.

Key Benefits

This injector provides a secure, contamination-preventing interface between drug containers and other PhaSeal components. The double-membrane technology maintains an airtight and leakproof environment throughout the entire transfer process. BDs engineering minimizes drug residue, ensures consistent pressure equalization, and reduces the risk of accidental disconnection. The single-use, sterile design supports maximum safety during high-risk oncology and pharmacy workflows.

Compatibility and Applications

The BD 515003 Injector N35 is compatible with the BD PhaSeal system and integrates seamlessly with:

• PhaSeal vial adaptors and syringe adaptors
• PhaSeal bag and tubing connectors
• Standard Luer-Lok syringes

Common use scenarios include:

• Preparation of chemotherapy in hospital pharmacies
• Safe mixing, transfer, and reconstitution of cytotoxic drugs
• Oncology infusion centers handling hazardous medications
• Closed-system drug administration in clinics, hospitals, and infusion suites

Usage Guidelines

Attach the Injector N35 to the appropriate PhaSeal component using sterile technique. Ensure both membranes are aligned before engaging the connection. Lock securely in place until a fully closed system is established. After drug transfer, disconnect following BDs recommended workflow to avoid contamination or pressurization issues. Discard the injector immediately after use in accordance with hazardous drug waste protocols.

Certifications, Safety Standards, and Regulatory Approvals

The Injector N35 is manufactured in ISO 9001 and ISO 13485 certified facilities and meets FDA and CE requirements for closed-system transfer devices. BD PhaSeal products comply with NIOSH recommendations for preventing occupational exposure to hazardous drugs and have been validated through independent vapor containment testing.

Comparison with Competitor Products

BD PhaSeal injectors offer industry-leading vapor containment and leak resistance. Competitors may rely on mechanical barriers that do not fully prevent aerosol escape or require multiple manual steps, increasing exposure risk. PhaSeals membrane-to-membrane sealing mechanism ensures a completely enclosed drug pathway, delivering superior protection and consistent performance across all drug-handling stages.

Typical User Profile and Application Scenarios

This injector is widely used by:

• Oncology pharmacists preparing hazardous drugs
• Nurses administering IV chemotherapy
• Hospital infusion centers and outpatient oncology clinics
• Specialty pharmacies managing cytotoxic medications
• Any facility requiring NIOSH-compliant hazardous drug handling

Best Practices for Use and Maintenance

Store injectors in their original sterile packaging until use. Do not attempt to reuse or reprocess. Follow recommended hazardous drug handling proceduresincluding PPE, biological safety cabinet use, and proper waste disposal. Ensure full engagement of PhaSeal components to maintain system integrity during drug transfer.

Regulatory and Safety Information

For use only with BD PhaSeal systems. Single-use sterile device. Not intended for reuse. Follow OSHA, NIOSH, USP, and institutional guidelines for hazardous drug handling and disposal. Dispose of used injectors as hazardous drug waste.

How to Order

To order the BD 515003 Injector N35 for PhaSeal, add the item to your cart and complete checkout through CIA Medicals secure online ordering system. For bulk orders, oncology pharmacy supply contracts, or technical support, contact CIA Medical customer service at (312) 275-5850 or submit an inquiry through the contact form on this page.